Home / Inspections / 796294

FDA Inspection 796294 — Hikma Pharmaceuticals USA, Inc.

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

The FDA completed an inspection of Hikma Pharmaceuticals USA, Inc. on August 28, 2012 in Eatontown, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 28, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eatontown, NJ (United States)

Facility

Other inspections at this facility

  • 1079961 (NAI Fri Feb 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1054739 (NAI Fri Apr 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976090 (NAI Thu Jul 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 942928 (NAI Thu Sep 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864847 (VAI Wed Feb 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources